MPM Capital
Overview
MPM Capital, also known as MPM BioImpact, is a world-leading biotechnology investment firm with nearly three decades of experience. The firm creates and invests in private and public companies across all stages of development that seek to translate scientific innovations into cures for major diseases, with a particular focus on biotechnology, life sciences, and oncology. MPM BioImpact combines the venture capital activities of MPM Capital with the impact and public equity investing of its affiliate, BioImpact Capital. The firm has been involved in the development of 60 FDA-approved drugs.
Portfolio Companies
21
Website
mpmcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sai Life Sciences | May 2008 | VC Round | Lead |
| Aktis Oncology | Sep 2024 | Series B | Co-investor |
| Tizona Therapeutics | Mar 2016 | Series B | Co-investor |
| Umoja Biopharma | Jan 2025 | Series C | Co-investor |
| ReCode Therapeutics | Sep 2023 | Series B Extension | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is MPM Capital based?
MPM Capital is headquartered in Boston, Massachusetts, United States.
When was MPM Capital founded?
Founding year information for MPM Capital is not publicly available.
How many portfolio companies does MPM Capital have?
MPM Capital has 21 portfolio companies in Caplight's dataset.
What are some companies in MPM Capital's portfolio?
Portfolio companies visible on Caplight include Sai Life Sciences, Aktis Oncology, Tizona Therapeutics, Umoja Biopharma, ReCode Therapeutics.
What was MPM Capital's most recent investment shown here?
MPM Capital's most recent investment in this portfolio sample was in Umoja Biopharma in 2025.
What sectors does MPM Capital focus on?
MPM Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does MPM Capital focus on?
MPM Capital typically invests at the MultiStage stage.
What is MPM Capital's AUM?
MPM Capital's assets under management are estimated at over $3.0B.